Randomized trial · people
Cerebrolysin: better arm function at day 90 after stroke in CARS
Checked against the paper Randomized trialPublished by PepVault
The takeaway
One placebo-controlled trial found better arm recovery after stroke when Cerebrolysin was added to early rehab, but it was exploratory and still needs a larger trial to confirm it.
- Kind
- Randomized trial
- Studied in
- People
- Published
- 2016
- Journal
- Stroke
What they tested
The team tested whether stroke patients given Cerebrolysin had better arm and hand movement at day 90 than patients given a placebo.
How the study was done
A randomized, double-blind, placebo-controlled phase II trial at several centers, in patients who had just had a stroke. They got Cerebrolysin (30 mL/d) or saline placebo once a day for 21 days, starting 24 to 72 hours after the stroke, and all joined a standard 21-day rehab program.

What they found
At day 90, the Cerebrolysin group scored higher than the placebo group on the Action Research Arm Test, a measure of arm and hand use. The team rated this a large advantage, with an effect size (a Mann-Whitney estimator) of 0.71 and a 95% confidence interval running from 0.63 to 0.79 (P<0.0001). When 12 outcome scales of overall status were combined, Cerebrolysin came out ahead by a small-to-medium margin, with an estimator of 0.62 (95% confidence interval from 0.58 to 0.65, P<0.0001). Only 3.8% of patients dropped out early, and safety was similar to placebo.
What it doesn’t show
This was an exploratory trial with a fairly small number of patients, so the team says a large trial is needed to confirm it. All patients started treatment within days of the stroke alongside rehab, so it does not show effects in later stroke recovery or without rehab.
The paper
Muresanu et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016.
The compound
More studies on Cerebrolysin
- Cerebrolysin: better NIHSS scores after stroke across nine trialsMeta-analysis · people · 2018
- Cerebrolysin beat placebo on global change in Alzheimer's at 6 monthsMeta-analysis · people · 2015
- Cerebrolysin: no overall benefit in acute ischemic stroke at 90 daysRandomized trial · people · 2012
- Every study on Cerebrolysin
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.